HomeProductsBioactive CompoundsApoptosisCaspaseIlk-IN-1
Chemical structure of CAS 1333146-24-9

Ilk-IN-1

In Stock•Starting at $114 for 1 mg•Purity ≥ 98%
CAS No.1333146-24-9
MDL No.N/A
MFC30H30F3N5O
MW533.60
InChI KeyGHBUPSVATJKTRR-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98%$114In Stock
5 mgTo Be Confirmed$279In Stock
10 mgTo Be Confirmed$360In Stock
25 mgTo Be Confirmed$441In Stock
50 mgTo Be Confirmed$561In Stock
100 mgTo Be Confirmed$803In Stock
200 mgTo Be Confirmed$1144In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1333146-24-9
Product NameIlk-IN-1
Heavy Atom Count39Rotatable Bond Count7
Atom Stereo Count0Bond Stereo Count0
HBA5HBD2
TPSA62.190 ŲCharge0
Exact Mass533.24025Complexity1405.24
pKa9.613XLogP5.313

Related Articles

Studies related to this compound and its mechanism of action

Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.

Virchows Archiv : an international journal of pathology • Vol. 456, Issue 3 • 2010
PMID: 20091050DOI: 10.1007/s00428-009-0866-z

ILK over-expression in human colon cancer progression correlates with activation of beta-catenin, down-regulation of E-cadherin and activation of the Akt-FKHR pathway.

The Journal of pathology • Vol. 208, Issue 1 • 2006
PMID: 16278819DOI: 10.1002/path.1860

Conditional knock-out of integrin-linked kinase demonstrates an essential role in protein kinase B/Akt activation.

The Journal of biological chemistry • Vol. 278, Issue 25 • 2003
PMID: 12686550DOI: 10.1074/jbc.M303083200

Expression of integrin-linked kinase is closely correlated with invasion and metastasis of gastric carcinoma.

Virchows Archiv : an international journal of pathology • Vol. 442, Issue 2 • 2003
PMID: 12596061DOI: 10.1007/s00428-002-0718-6

Documentation

Similar Products